Sabby Management, LLC Atossa Therapeutics, Inc. Transaction History

Sabby Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.59 - $0.91 $81,571 - $125,813	-138,257 Reduced 67.78%	65,714 $47,000
Q4 2022 Feb 14, 2023	SELL	$0.5 - $1.01 $103,962 - $210,004	-207,925 Reduced 50.48%	203,971 $108,000
Q3 2022 Nov 14, 2022	SELL	$0.82 - $1.14 $92,585 - $128,716	-112,909 Reduced 21.51%	411,896 $343,000
Q2 2022 Aug 15, 2022	BUY	$0.85 - $1.28 $138,323 - $208,298	162,733 Added 44.94%	524,805 $572,000
Q1 2022 May 16, 2022	BUY	$1.11 - $1.74 $401,899 - $630,005	362,072 New	362,072 $453,000
Q3 2021 Nov 15, 2021	SELL	$2.89 - $6.4 $3.02 Million - $6.69 Million	-1,045,987 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$1.52 - $8.62 $1.22 Million - $6.93 Million	803,750 Added 331.8%	1,045,987 $6.61 Million
Q1 2021 May 17, 2021	BUY	$0.92 - $4.33 $222,858 - $1.05 Million	242,237 New	242,237 $511,000
Q1 2019 May 15, 2019	SELL	$1.11 - $7.07 $557,717 - $3.55 Million	-502,448 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$0.92 - $1.67 $34,416 - $62,473	37,409 Added 8.04%	502,448 $513,000
Q3 2018 Nov 14, 2018	BUY	$1.47 - $2.78 $182,706 - $345,526	124,290 Added 36.48%	465,039 $814,000
Q2 2018 Aug 14, 2018	BUY	$2.2 - $5.28 $749,647 - $1.8 Million	340,749 New	340,749 $750,000

26.5M

466K

91.8K

Ticker ATOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,624,000
Market Cap $130M
Description
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sabby Management, LLC with notifications on news.